Search

Search Results
Results 4041 - 4050 of 5298 for Abused drugs
  • Panamax Co
    Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Panamax Co intended for persons living in Australia.
  • Innovative platform bridges the gap between OUD treatment and HIV prevention
    News - 22 May 2026
    People with opioid use disorder (OUD) are at increased risk of contracting human immunodeficiency virus (HIV). While there are effective interventions that can substantially reduce HIV incidence and...
  • Mersyndol
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Mersyndol intended for persons living in Australia.
  • Fluorescent biosensors for dynamic analysis of GPCR and arrestin interactions
    Health - 27 Nov 2025
    Fluorescent biosensors provide a powerful tool for studying dynamic GPCR signaling and arrestin recruitment across extended time scales. Learn more by reading the full article.
  • Codalgin Forte
    Drug - 6 Nov 2025
    Consumer Medicine Information (CMI) about Codalgin Forte intended for persons living in Australia.
  • Paracetamol/Codeine GH 500/30
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Paracetamol/Codeine GH 500/30 intended for persons living in Australia.
  • Comfarol Forte
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Comfarol Forte intended for persons living in Australia.
  • Codapane Forte
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Codapane Forte intended for persons living in Australia.
  • APX-Paracetamol/Codeine
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about APX-Paracetamol/Codeine intended for persons living in Australia.
  • GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients
    News - 17 Sep 2025
    Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback